Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 13Lung Neoplasms 9Carcinoma, Renal Cell 7Rectal Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Lymphoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Esophageal Neoplasms 4Breast Neoplasms, Male 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Kidney Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Esophageal Squamous Cell Carcinoma 3Brain Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Spinal Cord Neoplasms 2

Interventions

alfatide II 1Thoracotomy 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tuberculosis, Pulmonary × Fluorodeoxyglucose F18 × Clear all
NCT02481726 2015-06-25

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Xijing Hospital

Phase 1/2 Completed
31 enrolled
Thoracic

Lung Neoplasms, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡